Abstract Chris Papageorgio1, Robert Harrison2, Farahnaz B. Rahmatpanah3, Kristen Taylor3, Wade Da-vis4 and Charles W. Caldwell3
1Department of Internal Medicine/Division of Hematology Oncology, Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO 65203, USA; 2Department of Computer Science, P.O. Box 3994, Atlanta GA 30302, USA; 3Department of Pathology and Anatomical Sciences, Ellis Fischel Cancer Center, University of Missouri School of Medicine, Columbia, MO 65203, USA; 4Department of Medical Research, University of Missouri School of Medicine, Columbia, MO 65203, USA
Abstract
The computational aspects of the problem in this paper involve, firstly, selective mapping of methylated DNA clones according to methylation level and, secondly, extracting motif information from all the mapped elements in the absence of prior probability distribution. Our novel implementation of algorithms to map and maximize expectation in this setting has generated data that appear to be distinct for each lymphoma subtype examined. A “clone” represents a polymerase chain reaction (PCR) product (on average ~500 bp) which belongs to a microarray of 8544 such sequences preserving CpG-rich islands (CGIs) [1]. Accumulating evidence indicates that cancers including lymphomas demonstrate hypermethylation of CGIs “silencing” an increasing number of tumor suppressor (TS) genes which can lead to tumorigenesis.
Discussion
No comments yet...Be the first to comment.
I had an excellent experience publishing our review article in Clinical Medicine Reviews. The managing editor was very helpful and the process was very timely and transparent.Professor Jonathan A. Bernstein (University of Cincinnati College of Medicine, Division of Immunology, Allergy Section, Cincinnati, OH, USA) What our authors say
Copyright © 2010 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)